Literature DB >> 32315713

Matrix metalloproteinases shape the oligodendrocyte (niche) during development and upon demyelination.

Rianne P Gorter1, Wia Baron2.   

Abstract

The oligodendrocyte lineage cell is crucial to proper brain function. During central nervous system development, oligodendrocyte progenitor cells (OPCs) migrate and proliferate to populate the entire brain and spinal cord, and subsequently differentiate into mature oligodendrocytes that wrap neuronal axons in an insulating myelin layer. When damage occurs to the myelin sheath, OPCs are activated and recruited to the demyelinated site, where they differentiate into oligodendrocytes that remyelinate the denuded axons. The process of OPC attraction and differentiation is influenced by a multitude of factors from the cell's niche. Matrix metalloproteinases (MMPs) are powerful and versatile enzymes that do not only degrade extracellular matrix proteins, but also cleave cell surface receptors, growth factors, signaling molecules, proteases and other precursor proteins, leading to their activation or degradation. MMPs are markedly upregulated during brain development and upon demyelinating injury, where their broad functions influence the behavior of neural progenitor cells (NPCs), OPCs and oligodendrocytes. In this review, we focus on the role of MMPs in (re)myelination. We will start out in the developing brain with describing the effects of MMPs on NPCs, OPCs and eventually oligodendrocytes. Then, we will outline their functions in oligodendrocyte process extension and developmental myelination. Finally, we will review their potential role in demyelination, describe their significance in remyelination and discuss the evidence for a role of MMPs in remyelination failure, focusing on multiple sclerosis. In conclusion, MMPs shape the oligodendrocyte (niche) both during development and upon demyelination, and thus are important players in directing the fate and behavior of oligodendrocyte lineage cells throughout their life cycle.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Demyelination; Extracellular matrix; Matrix metalloproteinase; Multiple sclerosis; Oligodendrocyte progenitor cell; Remyelination

Mesh:

Year:  2020        PMID: 32315713     DOI: 10.1016/j.neulet.2020.134980

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Editorial: Perineuronal Nets as Therapeutic Targets for the Treatment of Neuropsychiatric Disorders.

Authors:  Caroline A Browne; Katherine Conant; Amy W Lasek; Juan Nacher
Journal:  Front Synaptic Neurosci       Date:  2022-06-10

2.  Single-nucleus transcriptome analysis reveals disease- and regeneration-associated endothelial cells in white matter vascular dementia.

Authors:  Daniel N Mitroi; Min Tian; Riki Kawaguchi; William E Lowry; S Thomas Carmichael
Journal:  J Cell Mol Med       Date:  2022-05-11       Impact factor: 5.295

3.  Hypermethylation of EFEMP1 in the Hippocampus May Be Related to the Deficit in Spatial Memory of Rat Neonates Triggered by Repeated Administration of Propofol.

Authors:  Nu Zhang; Zhiyi Liao; Pinwen Wu; Hao Fang; Guoping Cai
Journal:  Biomed Res Int       Date:  2020-12-19       Impact factor: 3.411

Review 4.  Matrix Metalloproteinase-9 as an Important Contributor to the Pathophysiology of Depression.

Authors:  Hongmin Li; Zhaofu Sheng; Suliman Khan; Ruiyi Zhang; Yang Liu; Yan Zhang; V Wee Yong; Mengzhou Xue
Journal:  Front Neurol       Date:  2022-03-18       Impact factor: 4.003

Review 5.  Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery.

Authors:  Pauline E M van Schaik; Inge S Zuhorn; Wia Baron
Journal:  Int J Mol Sci       Date:  2022-07-29       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.